The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALECTOR INC | COM | 014442107 | 14,841 | 980,894 | SH | SOLE | 980,894 | 0 | 0 | ||
| CONSTELLATION PHARMCETICLS I | COM | 210373106 | 15,965 | 554,325 | SH | SOLE | 554,325 | 0 | 0 | ||
| DENALI THERAPEUTICS INC | COM | 24823R105 | 27,117 | 323,749 | SH | SOLE | 323,749 | 0 | 0 | ||
| FIRST FINL BANCORP OH | COM | 320209109 | 3,043 | 173,576 | SH | SOLE | 173,576 | 0 | 0 | ||
| FOGHORN THERAPEUTICS INC | COM | 344174107 | 25,566 | 1,261,261 | SH | SOLE | 1,261,261 | 0 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 63,133 | 2,083,602 | SH | SOLE | 2,083,602 | 0 | 0 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 47,405 | 1,400,435 | SH | SOLE | 1,400,435 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 257,076 | 4,179,416 | SH | SOLE | 4,179,416 | 0 | 0 | ||
| RAPT THERAPEUTICS INC | COM | 75382E109 | 14,532 | 735,801 | SH | SOLE | 735,801 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 3,699 | 93,436 | SH | SOLE | 93,436 | 0 | 0 | ||